DaVita HealthCare Partners Inc (DVA)vsNutex Health Inc (NUTX)
DVA
DaVita HealthCare Partners Inc
$181.55
+0.12%
HEALTHCARE · Cap: $11.74B
NUTX
Nutex Health Inc
$200.24
+2.58%
HEALTHCARE · Cap: $1.32B
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 1555% more annual revenue ($14.01B vs $846.72M). NUTX leads profitability with a 21.2% profit margin vs 6.0%. NUTX trades at a lower P/E of 7.5x. DVA earns a higher WallStSmart Score of 70/100 (B).
DVA
Strong Buy70
out of 100
Grade: B
NUTX
Buy63
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-13.0%
Fair Value
$127.66
Current Price
$181.55
$53.89 premium
Margin of Safety
+61.7%
Fair Value
$269.07
Current Price
$200.24
$68.83 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Every $100 of equity generates 81 in profit
Earnings expanding 55.8% YoY
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Attractively priced relative to earnings
Strong operational efficiency at 57.8%
Earnings expanding 95.9% YoY
Every $100 of equity generates 28 in profit
Keeps 21 of every $100 in revenue as profit
Areas to Watch
6.0% margin — thin
Weak financial health signals
Distress zone — elevated risk
Smaller company, higher risk/reward
Revenue declined 13.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : DVA
The strongest argument for DVA centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.45 suggests the stock is reasonably priced for its growth.
Bull Case : NUTX
The strongest argument for NUTX centers on P/E Ratio, Operating Margin, EPS Growth. Profitability is solid with margins at 21.2% and operating margin at 57.8%.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Bear Case : NUTX
The primary concerns for NUTX are Market Cap, Revenue Growth.
Key Dynamics to Monitor
DVA profiles as a value stock while NUTX is a declining play — different risk/reward profiles.
NUTX carries more volatility with a beta of 2.02 — expect wider price swings.
DVA is growing revenue faster at 5.2% — sustainability is the question.
DVA generates stronger free cash flow (320M), providing more financial flexibility.
Bottom Line
DVA scores higher overall (70/100 vs 63/100). NUTX offers better value entry with a 61.7% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Nutex Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?